US4661509A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Methods for treating leukopenia
Assignee: Individual
•
Filing: 1984-02-21
•
Granted: 1987-04-28
•
Expires: 2004-02-21
Abstract
Abstract A method of improving the levels of formed blood elements in a patient having disease or therapy induced leukopenia comprising administering to said patient a therapeutically effective amount of a pharmaceutically acceptable, water or lipid soluble tertiary or quaternary amine having cholinergic or anticholinesterase activity.
Inventors
- 👤 Arnold Z. Gordon
- 👤 Arthur H. Rossof
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 21:16
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/66; A61K31/683; A61K31/685; A61K31/13; A61K31/135; A61K31/16; A61K31/165; A61K31/185; A61K31/205; A61K31/21; A61K31/265; A61K31/33; A61K31/335; A61K31/365; A61K31/395; A61K31/40; A61K31/41; A61K31/415; A61K31/435; A61K31/44; A61K31/445
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
45 words
A method of increasing the peripheral white blood cell count in a patient having disease or therapy induced leukopenia comprising administering to said patient a therapeutically effective amount of a pharmaceutically acceptable, water or lipid soluble tertiary or quaternary amine having cholinergic or anti-chlolinesterase activity.
Claim 2
Independent Claim
45 words
A method of increasing the peripheral white blood cell count in a patient having disease or therapy induced leukopenia comprising administering to said patient a therapeutically effective amount of a pharmaceutically acceptable, water or lipid soluble tertiary or quaternary amine having cholinergic or anti-chlolinesterase activity.
Claim 3
Dependent Claim
24 words
The method of claim 1 wherein said tertiary or quaternary amine is administered to a patient in need of said treatment via oral administration.
Claim 4
Dependent Claim
24 words
The method of claim 1 wherein said tertiary or quaternary amine is administered to said patient in need of said treatment via transdermal administration.
Claim 5
Dependent Claim
25 words
The method of claim 1 wherein said tertiary or quaternary amine is administered to said patient in need of said said treatment via subcutaneous administration.
Claim 6
Dependent Claim
45 words
The method of claim 1 wherein said tertiary or quaternary amine is selected from the group consisting of choline, acetylcholine, methacholine, carbachol, bethanacol, muscarine, arecoline, carbamylcholine, aceclinidine, pilocarpine, oxytremarine, neostigmine, edrophonium, physostigmine, pyridostigmine, demarcarium, ambenonium, octamethyl pyrophosphoramide, and diethyloxyphosphinylthiocholine or a pharmaceutically acceptable salt thereof.
Claim 7
Dependent Claim
10 words
The method of claim 1 wherein said compound is pilocarpine.
Claim 8
Dependent Claim
10 words
The method of claim 1 wherein said compound is neostigmine.
Claim 9
Dependent Claim
10 words
The method of claim 1 wherein said compound is choline.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-04-27 | 1990-10-27 | 1991-04-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-04-27 | 1994-10-27 | 1995-04-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-04-27 | 1998-10-27 | 1999-04-28 | $7700.00 | Window Closed / Lapsed |